Image alt Bayer Logo Bayer Logo Bayer Logo Bayer Logo

Standardisation of Definitions

What definitions have been standardised?

The nAMD Barometer Leadership Coalition have developed and validated standardised definitions for (non-)adherence/persistence in the context of nAMD treatment, in order to:

 

  • Increase awareness of the role and importance of adherence and persistence among healthcare professionals and patients
  • Set uniform parameters for future research
  • Allow benchmarks to be established in order to measure the impact of future interventions

Full adherence

A patient is considered fully adherent to anti-VEGF therapy in nAMD if...

They attend every scheduled clinic appointment* (treatment or monitoring), and undergo every treatment or monitoring procedure advised by the treating physician
 

Persistence

A patient is considered persistent to anti-VEGF therapy in nAMD if...

They maintain treatment or monitoring as advised by the treating physician AND attended their most recent appointment†

Adherence

A patient is considered adherent to anti-VEGF therapy in nAMD if...

They miss no more than one treatment or monitoring visit* scheduled as advised by the treating physician over a period of 1 year
 

Non-persistence

A patient is considered non-persistent to anti-VEGF therapy in nAMD if...

  • They do not attend any treatment or monitoring visit for any reason for a period of 6 months‡
  • Follow-up appointments are not scheduled for any reason for a period of 6 months‡
     

Non-adherence

A patient is considered non-adherent to anti-VEGF therapy in nAMD if...

They miss two or more treatment or monitoring visits* scheduled as advised by the treating physician over a period of 1 year

Planned discontinuation or transfer of care

A patient is considered to have a planned discontinuation as defined by...

  • Lack of treatment response (treatment futility) judged by the treating physician
  • No disease activity requiring ongoing treatment judged by the treating physician

A patient is considered to have their care transferred if...

The ongoing management of the patient’s nAMD is transferred to another physician